ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first.
Time
7,037 announcements with these filters
Classic Electrodes reported strong FY26 performance with 18.06% revenue growth and expansion into high-margin Railway components. Strategy focuses on automation and product mix optimization.
ADF Foods reported record Q4 FY26 consolidated revenue of ₹196.7cr, up 23.7% YoY, driven by strong penetration of Ashoka and Truly Indian brands.
Amagi delivered strong Q4 FY26 results, turning PAT-positive for the full year. Strategy focuses on an AI-powered 'glass-to-glass' cloud media infrastructure and monetization.
E To E Rail delivered strong FY26 performance with Revenue at ₹380 Cr (51.5% YoY) and PAT of ₹16.8 Cr.
Qualitek Labs delivered strong FY26 results with consolidated revenue of ₹124.5 Cr, a four-fold increase over FY24, driven by acquisitions and segment diversification.
IRB Infra reported strong FY26 PAT growth of 32% YoY despite a marginal 2% decline in total income, driven by robust toll revenue and operational efficiency.
Galaxy Surfactants reports Q4FY26 EBITDA at ₹122cr with EBITDA/MT of ₹20,114. India volumes grew 8% YoY, while AMET region declined 15% due to supply chain disruptions.
GPT Infra projects a strong growth trajectory following the Alcon signaling acquisition. Management is masking debt concerns with aggressive 25-30% growth guidance, leveraging a record order book despite recent execution delays caused by elections.
Talbros delivered record FY26 profits but faces execution pressure as a major European EV order is scaled back to a 50/50 hybrid split.
Piramal Finance achieved ₹1.5L Cr AUM growth trajectory with FY26 Consol. PAT of ₹1,506 Cr, up 210% YoY. Successfully transitioned to 85% retail-led AUM mix.
JG Chemicals reported record FY26 performance with Revenue of ₹972.9 Cr and PAT of ₹68.6 Cr. Strategy focuses on expanding zinc oxide capacity and diversifying into non-rubber segments like ceramics.
DCM Shriram delivered Q4 FY26 net revenue of ₹3,193 cr (up 11% YoY) and PBDIT of ₹400 cr. Focus remains on chemical value chain integration and sustainability.
Alembic Pharma delivered Q4 FY26 revenue of ₹1,838 Cr (up 4% YoY) and PAT of ₹203 Cr. FY26 revenue grew 10% YoY to ₹6,201 Cr with 25% EBITDA margins before R&D.
SJVN delivered a record FY25-26 performance with 13,302 MU generation. Revenue grew 18.98% to ₹3,869.66 cr, while Standalone PAT reached ₹1,007.90 cr with an 80.30% EBITDA margin.
Permanent Magnets Limited Q4FY26 revenue surged 47% YoY to ₹66cr, with full-year FY26 revenue at ₹225cr (up 13%). Strategy focuses on scaling Alloys, Relays, and Quantum Magnetics segments.
Swastika Castal reported strong FY26 performance with 19.5% revenue growth and 17.17% EBITDA margins. The company is pivoting toward higher value-add machined components.
Alivus (ex-Glenmark Life Sciences) reported strong Q4FY26 results with record 33.6% EBITDA margins, driven by non-GPL growth (71% of business) and CDMO recovery.
Bodal Chemicals reported Q4FY26 revenue of ₹5,906mn (up 30% YoY) and PAT of ₹321mn. Full-year FY26 revenue reached ₹20,539mn with EBITDA margins improving to 9.9%.
DOMS reported strong Q4FY26 growth with revenue up 21.6% for FY26. Management is focused on capacity expansion across stationery and baby hygiene (Uniclan) while navigating raw material volatility.
Aakaar Medical Technologies reported strong FY26 recovery with ₹66.9cr revenue and record H2 profitability driven by high-margin product launches and improved debtor discipline.
Siyaram delivered solid FY26 results with 15.5% revenue growth despite a one-time residential project pivot masking core textile focus. Management maintains a balanced outlook amid volatile input costs.
Saatvik reported record revenue and volumes for FY26 but faced significant margin compression in Q4 due to raw material inflation and fixed-price contracts.
EPACK faced a tough FY26 with falling revenues and margins due to adverse weather and inventory pile-ups, partially offset by a one-time RIPS incentive.
Capacit'e Infraprojects delivered a steady FY26 but faced execution headwinds from labor migration and elections, while aggressively flagging commodity price inflation risks for upcoming quarters.
Arvind Limited delivered robust Q4 FY26 results with EBITDA crossing the ₹1,000 Cr mark for the first time. Strategy focuses on garmenting expansion and advanced materials.
True Colors Limited reported FY26 revenue of ₹301.55 Cr with a 15.58% EBITDA margin, driven by its integrated digital printing ecosystem.
GEE Ltd reported FY26 revenue of ₹370cr with 9% EBITDA margins. Management is pivoting towards high-margin defense, nuclear, and specialized welding consumables to drive expansion.
Oriental Aromatics reported FY26 consolidated revenue of ₹10,308 Mn, up 11% YoY, despite a 91% drop in PAT to ₹32 Mn due to higher costs.
Emami's Q4FY26 was impacted by seasonal headwinds and West Asia geopolitical conflict, yet domestic non-summer portfolio grew 11%. Strategic acquisitions in Axiom Ayurveda and IncNut aim for future growth.
Sai Life Sciences reported robust FY26 performance with 29% revenue growth and 109% PAT growth, driven by deepening engagement with 19 of top 25 global pharma companies.